Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anthrax Vaccines
Study findings from LigoCyte Pharmaceuticals Inc. broaden understanding of anthrax vaccines
December 17th, 2008
Scientists discuss in 'A single immunization with a dry powder anthrax vaccine protects rabbits against lethal aerosol challenge' new findings in anthrax. "Here we confirm that intranasal (IN) dry powder anthrax vaccine formulations are able to protect rabbits against aerosol challenge 9 weeks after a single immunization. The optimum dose of rPA in our dry powder anthrax vaccine formulation in rabbits was experimentally determined to be 150microg and therefore was chosen as the target dose for all subsequent experiments," investigators in the United States report. "Rabbits received a single dose of either 150microg rPA, 150microg rPA+150microg of a conjugated 10-mer...
Source: Vaccine Weekly (2008-12-17)
|
